Archer closes in on feasibility testing for kidney disease sensors
Archer Materials (ASX:AXE) has announced progress in its development of graphene field effect transistor (gFET) sensors for its Biochip technology, a platform aimed at revolutionising chronic kidney disease diagnostics.
Read More